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Abstract 
Background: In the United States, more people die from drug overdoses related to increased 
heroin and fentanyl use than homicides and car accidents combined (Sederer & Marino, 2018). 
Frustrations and negative perceptions (stigma) on behalf of primary healthcare providers may 
result in negative health outcomes for patients, poor therapeutic relationships and lack of 
opportunity to engage clients in substance use treatment (Khenti et al., 2017). 
Purpose: The purpose of this project was to implement a contact-didactic education module to 
improve adult gerontology primary care (AGPCNP) and family nurse practitioner (FNP) 
students’ attitudes towards OUD patients, and to increase their therapeutic commitment to and 
confidence in working with patients seeking primary care treatment with co-occurring opioid use 
disorders. 
Methods: The project utilized a pre and post-test design. The Drug and Drug Problems 
Questionnaire (DDPPQ) and a nurse practitioner confidence scale (NPCS) were administered pre 
and post intervention to AGPCNP and FNP students finishing their second year of a Doctor of 
Nursing Practice (DNP) program.  
Significance: The implemented education module resulted in statistically significant decrease in 
scores on the DDPPQ, indicating reduced stigma, and increased NPCS scores indicating 
increased confidence. A statistically significant inverse correlation was noted between NPCS 
scores and DDPPQ scores. 
 
Keywords: opioid use disorder, substance use disorder, primary care, stigma, social capital, 
attitudes, nursing education, therapeutic relationship 
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Increasing the Confidence of  Primary Care Nurse Practitioner Students in Caring for Patients 
with Preexisting Opioid Use Disorder 
Background and Significance 
The opioid crisis in the United States continues and opioid related mortality rates 
nationwide remain staggering. With an increase in opioid use comes comorbid illnesses. The 
combined impact leads to greater interaction with healthcare providers in primary care clinics, 
including adult-gerontology primary care (AGPCNP) and family nurse practitioners (FNP), who 
are increasingly prominent in the healthcare workforce. This increased interaction with health 
care providers presents an opportunity to improve the response to the opioid crisis and increase 
the skills and knowledge needed to care for these individuals. 
In 2013, 4.3 million persons aged 12 and older had an illicit drug use disorder (Crowley 
& Kirschner, 2015).  By 2016, this number had increased to 7.4 million people, with 2.1 million 
of these individuals having an opioid use disorder (Ahrnsbrak, Bose, Hedden, Lipari, & Park-
Lee, 2017). This is a substantial increase in just a three-year timeframe. An estimated 142 people 
in the U.S. die from drug overdoses every day, due to the increased use of heroin and fentanyl 
additives; more than motor vehicle accidents and homicides combined (Sederer & Marino, 
2018). Risk of mortality for individuals with opioid use disorders have risen to 20 times higher 
than that of the general population, and opioid mortality rates in general have skyrocketed- 
particularly with the surge in prescription opioid misuse over the last 20 years (Watkins, et al., 
2017). This spike is alarming, and the numbers suggest the problem becoming more widespread 
throughout the United States.  
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Kentucky is tied for third highest in deaths related to drug overdose per capita nationwide 
(Hauser, 2017). Rates of overdose fatalities in the state of Kentucky reached 1,404 as of June 
2017; and Jefferson county had the most overdose deaths of any county in the state (Tilley & 
Ingram, 2018). The Louisville Metro area has been particularly hard hit. In early February of 
2017, there was a 32-hour period during which Emergency Medical Services (EMS) responded 
to approximately two overdose calls per hour; annual instances of EMS calls for overdose had 
risen to 6,879 in 2016 (Hauser, 2017). Beyond this alarming trend, as a result of the increase in 
intravenous (IV) drug use, out of 220 counties in the entire United States with increased 
vulnerability to Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) 
dissemination, 54 of these were in Kentucky (Centers for Disease Control and Prevention 
[CDC], 2018). 
While overdose rates are obvious, comorbid conditions related to long-term OUDs are 
often overlooked by the general public as well as the healthcare industry. These comorbid 
illnesses are debilitating and often require medical attention or hospitalization- they run the 
gamut from injection site infections and abscesses to HIV and HCV. It is worth noting here that 
OUDs are a subset of general SUDs and, while the research often broadens the scope to examine 
SUDs in general, for the purposes of this paper the terms will be used interchangeably as the 
stigma and disease process components are equally relevant. The rise of the opioid epidemic has 
led to increased contact with the medical community as these patients seek or require treatment 
for complications related to persistent opioid use (Dion, 2015). This increase in medical 
intervention, particularly in primary care settings, presents an opportunity for AGPCNPs and 
FNPs to intervene. 
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Unfortunately, healthcare providers often hold prejudiced views towards OUD patients. 
This is not exclusive to AGPCNPs and FNPs; however. According to van Boeckel, Brouwers, 
Weeghel, and Garretsen (2013), healthcare professionals who do not specialize in addiction, 
when compared to psychiatrists and addiction specialists, are more likely to view OUD as a 
character flaw and not a medical problem, and had the lowest regard for working with this 
population. This is problematic if the hope is for the medical community to intervene and reduce 
the impact of this epidemic. These challenges can lead to poor patient outcomes, lower patient 
satisfaction scores, frustrated staff, as well as missed opportunities for meaningful and effective 
intervention. 
Stigma is among the most pervasive, yet least discussed, issues facing healthcare today. It 
is considered to be a mark of shame and disqualifying characteristic concerning an individual in 
the eyes of a larger group. Stigma is based in social relationships and pervades all levels of 
culture (Pescosolido & Martin, 2015). This means that nobody is immune to stigma, and every 
member of society is impacted in some way. The process by which this occurs consists of the 
labelling of a stigmatized group, and the association of said labels with other negative qualities; 
these individuals are thus given a lower social status (Kennedy-Hendricks et al., 2017). While 
stigma touches the life of every person in a society, there are groups who tend to be 
disproportionately affected. As stigma is a function of society and culture, it necessarily varies 
based on these norms changing over time. At present, however, chief among those 
disproportionately affected are patients with mental health disorders and, specifically, 
SUDs/OUDs. There were three million federal and state prison admissions between 2003 and 
2011 related to or involving illicit substances, and this contributes to the stigmatization of SUD 
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as moral weakness rather than a medical disorder requiring health care intervention (Wakeman & 
Rich, 2018).  
Most healthcare professionals enter the field with high ideals or, at the least, good 
intentions. Healthcare providers are not immune to stigmatizing beliefs or behaviors. While 
stigma of persons with substance use disorders is widespread, in health care settings this stigma 
leads to missed opportunities to assist the patient in attaining improved health outcomes (Khenti 
et al., 2017). Stigma among primary healthcare providers in care provision for persons with 
opioid use disorders can lead to frustration among the providers and negative outcomes for the 
patients (van Boekel, Brouwers, van Weeghel, & Garretsen, 2013; Dion, 2015). It is important to 
note, however, that research demonstrates that it is possible to reduce stigma and increase nurse 
practitioner confidence in providing care for this population. 
 In general, people are far more likely to hold negative beliefs and attitudes toward 
individuals with SUDs when compared to other emotional or mental health issues (Henderson & 
Dressler, 2017). It therefore stands to reason that patients with OUD, having experienced stigma 
in life, will anticipate it in seeking help. Unfortunately, the research suggests that stigma 
continues to be demonstrated towards patients with OUDs in healthcare settings across the 
United States. Stigmatization in healthcare settings has a range of poor patient outcomes, from 
coercive treatment of this patient population, to being provided with insufficient information, to 
patronization and humiliation (Khenti et al., 2017).  
Patients experiencing SUDs and OUDs may avoid seeking treatment or assistance from 
the medical community as a result of the stigma they live with day-to-day (Henderson & 
Dressler, 2017). The complications associated with stigma are often internalized, leading to poor 
self-esteem, and, as a result, lower levels of social functioning (Ersöğütçü & Karakas, 2016). 
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Self-stigmatization creates a self-fulfilling and detrimental cycle as increased stigma leads to 
decreased social functioning, which can reinforce and worsen stigma. According to Kulesza, 
Watkins, Ober, Osilla, and Ewing (2017), there is evidence to suggest that internalized stigma is 
positively correlated with substance use problems in primary care patients, as well as poor health 
outcomes in general.  
The opioid crisis is multi-faceted and complex. The engagement of health care providers 
will be an imperative piece of any initiative to combat the situation. The prejudices and 
frustration on behalf of  primary healthcare providers is important to address for that very reason. 
Some of these prejudices are difficult to quantify, but the evidence supports that many of these 
issues can be addressed through contact with persons who are successful in recovery, resulting in 
stigma reduction and increased provider confidence. 
Problem Statement 
 OUD’s are on the rise across the country and this has led to increased contact with 
general practitioners. As adult gerontology primary care and family nurse practitioners have a 
larger role in the primary care workforce, there has been increased contact between these 
providers and persons with OUDs as they seek treatment for comorbid medical conditions. A 
lack of understanding of OUDs or effective communication strategies to successfully employ can 
lead to stigmatic views towards persons experiencing OUDs and a lack of therapeutic 
commitment. Therapeutic commitment is an inclination towards providing therapeutic care to 
patients with OUDs. The stigma experienced by this population in dealing with primary care 
providers then dissuades the seeking out of healthcare, ignores an opportunity for meaningful 
intervention, perpetuates the cycle of stigma and continued negative outcomes for the individual, 
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the family and the community. This state of affairs cannot continue if the medical community 
hopes to intervene concerning the opioid crisis and save lives. 
Summary of Evidence 
Electronic databases CINAHL, Medline via PubMed, and Psycinfo were searched 
utilizing the keywords: opioid use disorder, substance use disorder, stigma, social capital, 
attitudes, nursing education, and therapeutic relationship in various combinations. The articles 
that were selected focused on either stigma, were related to SUD, OUD, and mental illness, or 
addressed successful methods in addressing stigma and negative attitudes towards SUD, OUD, 
or mental illness. All 30 articles included were published in the last twenty-three years, with 24 
of these in the last six years. The articles consisted of descriptive, qualitative, meta analyses, and 
cohort studies. Additionally, there was one doctoral dissertation included and a PowerPoint 
presentation concerning effective communication techniques.  
Educational Interventions 
The research supports the notion that the implementation of a mixed methods training 
program focusing on communication strategies, biopsychosocial, and sociocultural aspects of 
SUDs/OUDs with additional contact-based education could reduce stigma and increase 
confidence levels in providing care for patients with co-occurring OUD/SUD. It also underscores 
the negative impact that stigma has on this population and the negative health outcomes 
associated therewith.  
There is strong evidence to suggest that the contact-based education approach, is a critical 
component in addressing the issue of stigma among healthcare providers. Contact-based  
education utilizes contact with a representative of the population to glean insight into the lived 
experience of the broader population he/she represents. In this project, a healthcare professional 
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living with and managing a substance use disorder provided education on stigma and OUDs.  
According to the National Academies of Sciences, Engineering, and Medicine, (2016), the 
evidence shows a consistent inverse relationship between contact interventions and levels of 
stigma. A meta-analysis completed by Corrigan, Michaels, Rafacz, and Rusch (2012), 
demonstrated that effect sizes for contact-based education and trainings on attitude change and 
intended behaviors were twice those which utilized education alone. The notion that people who 
are living with and successfully managing mental or substance use disorders are extremely 
potent resources in reducing stigma has been validated in numerous research studies, and this 
paradigm for delivering a message has proven to be extremely powerful in promoting empathy- 
helping lessen or eliminate stigma on behalf of the target audience (National Academies of 
Sciences, Engineering, and Medicine, 2016).  
Stigma and Bias 
 Capurso and Shorter (2017) discussed the belief that mental illness and substance use 
disorders are moralistic rather than biological concerns as contributory to stigma, and a 
substantial bias to be overcome. Furthermore, according to Bartlett, Brown, Shattell, Wright, and 
Lewallen (2013), recognizing substance use disorders as a disease like any other will be 
imperative to the alleviation of stigma and, indeed, any progress towards alleviation of the 
condition itself. Emphasizing the neurological changes that occur in the brain with OUD’s 
provided a scientific framework through which to view the condition and provide a rationale for 
a scientific, as opposed to moralistic, appraisal of the condition.  
Biopsychosocial Education 
The biopsychosocial issues related to substance use disorders and communication 
strategies have been identified as important points for education and training as it relates to 
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improving nurse confidence levels (Nash et al., 2017). A study by Anda et al., (2006), illustrated 
the link between adverse childhood experiences and the development of substance use disorders, 
with four or more of these experiences strongly correlated to IV drug use in adulthood. This type 
of biopsychosocial training module has also demonstrated efficacy in stigma reduction. 
According to Griffiths, Carron-Arthur, Parsons, and Reid (2014), there was a statistically 
significant reduction in stigma resulting from educational interventions even when performed 
alone across a variety of mental health conditions. Furthermore, a recent Harvard study 
recommended didactic education in attempting to improve attitudes among psychiatric residents 
towards SUD patients (Avery & Zerbo, 2015).  
Communication Techniques 
Communication techniques, specifically those incorporating motivational enhancement, 
have been effective in improving nurse-patient interactions with patients experiencing 
OUD/SUD (Fornili, Burda & Selby, 2018). Motivational enhancement techniques enable 
healthcare workers to meet the patient where he/she is regarding readiness to change behavior 
and maximize the motivation to move towards this behavior change. Approaching patients in a 
therapeutic manner is imperative if we hope to combat the opioid crisis. There is evidence to 
suggest that even if patients are not amenable to receiving information about drug treatment or 
are not interested in stopping substance use at the time of hospitalization, they will reap positive 
benefit by simply having the subject approached in a compassionate manner with information 
about treatment options provided (Bartlett et al, 2013). 
Theoretical Framework 
This education intervention was guided by the Framework Integrating Normative 
Influences on Stigma (FINIS) (Pescosolido & Martin, 2015). FINIS considers the factors that 
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drive stigma, most basically, as the interface between individual and community influences. 
There are three levels of influence,  micro, meso and macro. The micro level involves 
psychological and sociocultural factors on the individual level- the individual AGPC/FNP. The 
meso level includes social networks and organizations, the healthcare and professional 
environment. The macro level consists of society wide factors, historical, media and policy 
environment. These set the process of stigmatization in motion and define the creation and 
maintenance of stigma across a host of avenues. 
 FINIS helped focus this intervention on two of these levels: micro and meso 
(Pescosolido, Martin, Lang, & Olafsdottir, 2008). It is a bottom to top approach beginning at a 
largely grassroots level with the hope of influencing attitudes and increasing knowledge levels 
specifically at a point where individual and community influences converge and coexist. Stigma 
is a phenomenon of social norms, relationships, and culture, so it is necessary for solutions 
seeking to address stigma to focus on social relationships and the structures underpinned by these 
stigmatic views (Pescosolido & Martin, 2015). In the case of this intervention, these structures 
and relationships consisted of the  primary healthcare provider (specifically, the AGPCNP and 
FNP students) as representatives of the healthcare system on the meso level and the patient-
provider relationship on the micro or individual level.  
Purpose 
The purpose of this quality improvement project was to implement a contact-education 
training on OUDs, with the goal of reducing stigma among ACPCNPs and FNPs students who 
will be entering practice in primary care and caring for patients with co-occurring OUDs. 
Additionally, objectives included an increase in therapeutic commitment to and an improvement 
of attitude towards patients with comorbid OUD. Increased therapeutic commitment and 
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improved attitudes towards working with patients with co-occurring OUDs increase the 
likelihood of patients with OUDs receiving compassionate care and being guided towards 
positive health care outcomes. Improved understanding of addiction, with improved 
communication and confidence may result in a more empathetic and accessible health care 
system. 
Methods 
Setting and Organizational Assessment 
The setting was a class session in the course on Mental Health in Primary Care for FNP 
and AGPCNP students at a southeastern, metropolitan university in a DNP program. 
Participants 
The target population was graduate nursing students attending a course on mental health 
in primary care for AGPCNP and FNP students in the sixth semester of a three-year DNP 
program. Exclusion criteria included enrollment in another specialty not focused on primary 
care. There was no requirement of any kind to participate in the survey, and this was made clear 
prior to survey distribution to all participants. All 17 students participated in the class as part of 
the requirement for the course, but completion of the surveys was strictly voluntary. 
Intervention 
The education module took 100 minutes and was divided into short teaching segments as 
follows: 10 minutes for initial survey completion, 30 minutes for the contact-based component, 
30 minutes for the didactic component, 20 minutes to practice the communication techniques, 
and 10 minutes to administer the post test. The contact-based component of the intervention 
consisted of a brief presentation on OUD by a registered nurse who was successfully living with 
and managing SUD. The contact-based presentation reviewed the typical presentation of persons 
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with OUD/SUD and their similarity to other chronic conditions that are often similar to issues 
with periods of remission and exacerbation or adherence (e.g., diabetes and chronic obstructive 
pulmonary disease). Issues surrounding the resources available to a patient with OUD were also 
reviewed. The speaker presented her background with SUD, and she emphasized the importance 
of instilling hope and providing resources. This gave the participants the opportunity to connect 
with the human face of addiction and the importance of compassionate care in helping persons of 
OUD lead healthy lives.  
The didactic presentation considered OUD from a biopsychosocial perspective- it was 
solution-oriented, connecting current health and social issues with continued substance use, an 
emphasis on harm reduction strategies, and practice with communication strategies to promote a 
non-judgmental relationship. The biological components centered on the concepts of tolerance, 
withdrawal and delay discounting, specifically as they relate to behaviors in seeking primary care 
treatment in this patient population. Delay discounting refers to the extent to which a given 
reward loses perceived value based on the length of time it will take to acquire it. It is a 
phenomenon often augmented in patients who are dealing with OUD (Karakula et al., 2016). In 
decision making processes, the immediacy in receiving the reward weighs heavily (Matta, 
Gonçalves, & Bizarro, 2012). An example of delay discounting is in one spending money on an 
expensive car to be enjoyed right away as opposed to saving for a more comfortable retirement 
later. For patients with OUD however, an increase in delay discounting can lead to the sacrifice 
of physical health, or risk legal involvement in the acquisition of the reward. 
The delay discounting and presentation of behaviors as motivated by tolerance and 
withdrawal issues incorporate the biological and psychological factors inherent in the 
biopsychosocial model. The main psychological focus, however, dealt with the link between 
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adverse childhood experiences (ACEs), trauma history and SUDs/OUDs. According to Anda et 
al., (2006), there is a direct correlation between having four or more ACE’s and substance use 
risk, particularly as it relates to IV drug use. Heritability of trauma and its impact on risk for 
psychological problems in offspring was also touched on, as described by Santavirta, Santavirta, 
and Gilman, (2017). Understanding the link between traumatic events in childhood and 
SUD’s/OUD’s allows a more humanistic and empathetic view of these conditions to develop. 
This also ties into the social determinants of the development of SUD/OUD.  
Communication strategies were demonstrated and practiced among the participants. 
Motivational enhancement is a communication strategy of meeting people where they are in 
terms of their readiness for change (Fornili, Burda, & Selby, 2018). The two key tenets of 
motivational enhancement are to avoid pushing someone who is not ready to change and to 
gently prepare them for change. The specific motivational enhancement techniques that were 
covered included the elicitation of self-motivating statements, affirming the patient, and handling 
resistance. Eliciting self-motivating statements is a technique designed to get patients to state 
their own reasons for behavior change as opposed to telling the patient what to do; affirming the 
patient involves finding opportunities to reinforce the patient and, in particular, his/her 
motivation to strengthen the relationship and contribute to patient empowerment; handling 
resistance consists of strategies to effectively respond to patient resistance when discussing 
issues with OUD (Miller, Zweben, DiClemente, & Rychtarik, 1995). A handout with key points 
about these techniques was provided to the participants (see Appendix E).  
Participants were given a pamphlet with information about treatment options and 
resources for homelessness, OUD and SUD (Ice House Inc., n.d.).that could be distributed to 
their patients. This provides patients with information about treatment options, and served as  a 
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resource for AGPCNP/FNP students to have a greater knowledge of the local programs and 
supports available to improve the individual patient experience as well as the greater opioid 
crisis.  
Ethical Considerations and Institution Review 
This was a quality improvement project reviewed by the University of Louisville 
Institutional Review Board and deemed not human subjects research. Therefore, the project did 
not require full IRB review. There was no identifying information collected, and all institutional 
guidelines were followed. 
Project Design 
A pretest-post test design was used for this project.  
Measures 
The Drugs and Drug User’s Problems Perceptions Questionnaire (DDPPQ) was used to 
measure student attitudes and therapeutic commitment towards working with OUD patients (see 
Appendix A). The DDPPQ is a 22-item survey, derived from the original alcohol and alcohol 
problems perceptions questionnaire (AAPPQ) and measures attitude towards working with and 
therapeutic commitment towards SUD patients.  The scale utilizes a 7-point Likert scale to rank 
the extent of their agreement with a series of questions about work with SUD patients, with 1 
meaning “strongly agree” and 7 meaning “strongly disagree”. Lower scores mean more positive 
outlooks, and higher scores mean more negative outlooks.  
The DDPPQ demonstrated acceptable test-retest reliability (p=0.14) and good internal 
consistency with an alpha coefficient of 0.87 (Watson, MacLaren, & Kerr, 2007). The DDPPQ 
contains five component subscales. Component 1 consists of seven items related to role 
adequacy and has an alpha coefficient on 0.94 (Watson, MacLaren, & Kerr, 2007). Component 2 
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consists of three items related to role support, and has an alpha coefficient of 0.78 (Watson, 
MacLaren, & Kerr, 2007). Component 3 consists of four items related to job satisfaction with an 
alpha coefficient of 0.80 (Watson, MacLaren, & Kerr, 2007). Component 4 consists of four items 
concerning role-related self-esteem and has an alpha coefficient of 0.69 (Watson, MacLaren, & 
Kerr, 2007). Component five consists of two items related to role legitimacy, and has an alpha 
coefficient of 0.89 (Watson, MacLaren, & Kerr, 2007). 
The participants also completed an Adult Gerontology Primary Care and Family Nurse 
Practitioner Confidence in Caring for Persons Experiencing OUD Scale (NPCS) developed by 
the author for this project (see Appendix B). This measured AGPCNP and FNP confidence level 
in care provision to persons with co-occurring OUD in five specific domains. These included 
approaching patients with OUDs about their condition, engaging in motivational enhancement 
techniques, instilling hope, providing resources and maintaining a therapeutic mindset. The scale 
utilized a 5-point Likert scale with 1 being “not at all confident” and 5 being “totally confident”.  
A process evaluation was completed following the presentation of the education modules 
(see Appendix C). The purpose of the process evaluation was for the students to rate the 
presenters and efficacy of the intervention in meeting three primary objectives: examining the 
importance of stigma reduction in caring for SUD/OUD patients by AGPCNP/FNP’s, 
demonstrating motivational enhancement communication techniques for use with clients with 
OUD/SUD, and discussing practices and resources to increase confidence in care provision for 
clients with OUD/SUD. This was rated on a 4-point Likert scale with 1 being “strongly disagree” 
and 4 being “strongly agree”. 
The demographic information sheet was completed (see Appendix D). This contained 
questions to collet non-identifying, demographic data including age, race, gender, current 
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position, years in current position, years in nursing related field, prior experience in mental 
health or substance use treatment, and highest degree completed. 
Data Collection 
 At the beginning of the class session, all participants received a numbered packet 
containing the DDPPQ, Adult Gerontology Primary Care and Family Nurse Practitioner 
Confidence in Caring for Persons Experiencing OUD Scale. The participants completed these 
measures as well as the demographic data. The completion of these scales provided the baseline 
prior to the intervention. The educational intervention, both didactic and contact-based 
components, was then presented. Immediately following the intervention, the participants 
received a second packet with the DDPPQ, AGPC/FNP Confidence in Caring for Persons 
Experiencing OUD Scale, and the process evaluation form. These packets were numbered 
corresponding to the original packets. There was no identifying information associated with the 
responses. The survey responses were kept in a locked office at the University of Louisville 
Health Science Campus, with electronic copies of the information kept securely on an encrypted 
laptop computer. All HIPAA policies and procedures were followed.  
Data Analysis  
Data analysis was performed using SPSS v.22. Descriptive statistics were used to 
summarize demographic and clinical characteristics. Paired t-tests were used to examine the 
impact of the intervention on the DDPPQ and NPCS participant scores. Pearson Product Moment 
Correlation was used to determine the relationship among the dependent variables and 
demographic characteristics. 
Results 
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There were 17 total participants (N=17) for this intervention. The majority of participants 
were 20-30 years old (n = 10; 58.1%), Caucasian (n = 15; 88%), and identified as female (n = 16; 
94%). All were BSN prepared and enrolled in the Family Nurse Practitioner track or the Adult-
Gerontology Primary Care Nurse Practitioner track of the DNP program. The majority of 
participants worked in nursing for six years or less (n = 12; 70.6%). Approximately, one-third (n 
= 6; 35%) had past mental health or substance use disorder related work experience.  
A paired-samples t-test was conducted to evaluate the impact of the intervention on 
participants’ scores on the DDPPQ. There was a statistically significant decrease in DDPPQ 
scores from Time 1 (M=77.75, SD=22.65) to Time 2 (M=55.75, SD= 18.25), t (4.45), p <.01 
(two-tailed). The mean decrease in DDPPQ scores was 22 with a 95% confidence interval 
ranging from 11.45 to 32.55 (Table 1).  
The six subscales were also analyzed utilizing paired-samples t-tests to evaluate the 
impact of the intervention on participants’ scores on the respective subscales (Table 1). A paired-
samples t-test was conducted to evaluate the impact of the intervention on participants’ scores on 
the DDPPQ subscale related to role adequacy (subscale 1). There was a statistically significant 
decrease in subscale 1 scores from Time 1 (M=29.24, SD=6.25) to Time 2 (M=20.65, SD=6.61), 
t (4.82), p < .01 (two-tailed). The mean decrease in subscale 1 scores was 8.59 with a 95% 
confidence interval ranging from 4.81 to 12.37.  
A paired-samples t-test was conducted to evaluate the impact of the intervention on 
participants’ scores on the DDPPQ subscale that deals with role legitimacy (subscale 2). There 
was a statistically significant decrease in subscale 2 scores from Time 1 (M=8.06, SD=3.38) to 
Time 2 (M=5.94, SD=2.83), t (3.57), p < .01 (two-tailed). The mean decrease in subscale 2 
scores was 2.12 with a 95% confidence interval ranging from .86 to 3.38. 
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 A paired-samples t-test was conducted to evaluate the impact of the intervention on 
participants’ scores on the DDPPQ subscale that deals with role support (subscale 3). There was 
a decrease in subscale 3 scores from Time 1 (M=14.47, SD=15.44) to Time 2 (M=7.06, 
SD=3.70), t (2.06), p .056 (two-tailed).  The mean decrease in subscale 3 scores was 2.12 with a 
95% confidence interval ranging from .86 to 3.38. This result was not statistically significant. 
A paired-samples t-test was conducted to evaluate the impact of the intervention on 
participants’ scores on the DDPPQ subscale that deals with motivation (subscale 4). There was a 
statistically significant decrease in subscale 4 scores from Time 1 (M=3.29, SD=1.50) to Time 2 
(M=2.65, SD=1.41), t (3.10), p < .05 (two-tailed). The mean decrease in subscale 4 scores was 
0.65 with a 95% confidence interval ranging from .20 to 1.10. 
Subscale 5 dealt with role-related self-esteem. There was a decrease in subscale 5 scores 
from Time 1 (M=8.89, SD=3.35) to Time 2 (M=7.65, SD=3.41), t (1.84), p .09 (two-tailed). The 
mean decrease in subscale 5 scores was 1.24 with a 95% confidence interval ranging from -.19 to 
2.66. This decrease was not statistically significant. Subscale 6 concerned work satisfaction, and 
there was a decrease in subscale 6 scores from Time 1 (M=14.19, SD=5.04) to Time 2 
(M=11.88, SD=5.06), t (1.87), p .08 (two-tailed). The mean decrease in subscale 6 scores was 
2.31 with a 95% confidence interval ranging from -.32 to 4.94. This result was not statistically 
significant.  
A paired-samples t-test was conducted to evaluate the impact of the intervention on participants’ 
scores on the NPCS. There was a statistically significant increase in NPCS scores from Time 1 
(M=15.18, SD=3.56) to Time 2 (M=20.94, SD= 2.41), t (-9.10), p <.01 (two-tailed). The mean 
increase in NPCS scores was -5.76 with a 95% confidence interval ranging from -7.11 to -4.42.  
Table 1 
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11.45-32.55 4.45 <.001 
Role Adequacy** 29.24  
(6.25) 
20.65 (6.61) 4.81-12.37 4.82 <.001 
Role Legitamcy* 8.06 (3.34) 5.94 (2.84 .86-3.38 3.57 .003 
Role Support 14.47 
(15.44) 
7.06 (3.70) -.20-15.02 2.06 .056 
Motivation* 3.29 (1.49) 2.65 (1.41) .20-1.09 3.10 .007 
Role-related Self-
esteem 
8.88 (3.35) 7.65 (3.41) -.19-2.66 1.83 .085 
Role Support 14.19 (5.04) 11.88 (5.06) -.32-4.94 1.87 .081 
NPCS** 15.06 20.88 -7.25 - -4.38 -8.65 <.001 
* Correlation is significant at the 0.05 level (two-tailed) 
** Correlation is significant at the 0.01 level (two-tailed) 
 
 Other variables were analyzed for correlation among pre and post measures. These 
variables included age, gender, years in current role, and years of prior mental health experience. 
There was a strong positive correlation between age and NPCS pretest scores (r=.596 n=17 
p<.05) with increased age correlated with increased levels of nurse practitioner initial confidence 
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in providing care for patients with co-occurring OUD (Table 2). None of the other analyses 
demonstrated significant correlations. 
Table 2 
Correlation Among Pre and Post DDPPQ and NPCS and Prior MH/SUD Experience 
 1 2 3 4 5 
1. DDPPQ Pretest --     
2. DDPPQ Posttest .549* --    
3. NPCS Pretest -.293 -.136 --   
4. NPCS Posttest -.354 -.483* .679** --  
5. Prior MH/SUD 
Experience 
.009 -.150 .497* .334 -- 
* Correlation is significant at the 0.05 level (two-tailed) 
** Correlation is significant at the 0.01 level (two-tailed) 
  
Of the 17 total participants, 15 completed the post session evaluation. The majority of 
participants strongly agreed that the objectives were met: 93.3% strongly agreed that examining 
the importance of stigma reduction was met; 80% strongly agreed that motivational enhancement 
techniques were demonstrated; 93.3% of participants strongly agreed that practices and resources 
to increase confidence in care provision were discussed. All of the participants who completed 
the post session evaluation (n=15) indicated that all three objectives were met. 
 A latent content analysis was completed based on elements of the intervention as codes. 
Of the 17 participants who completed a pre-test, ten provided comments. There were 21 
comments made by the respondents. These fell into three main categories: general comments, 
most helpful, and areas for improvement. There was only one general comment which was “very 
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friendly and interactive”. Regarding the most helpful category, there were three main elements 
identified: case studies, contact, and resources. There were four respondents who identified case 
studies as being most helpful; one stated “The case studies were helpful in sparking discussion 
and helping to cement ideas that were presented.” Contact was identified as most helpful by four 
respondents; one identified the “real world experiences.”  The resources provided were identified 
as most helpful by three respondents. One respondent also identified the motivational 
enhancement techniques as most helpful, while another identified the statistics related to the 
opioid crisis.  
 The comments on suggestions for improvement were more varied. Areas of improvement 
were: implementation of early identification strategies; pictures and images of patients with 
OUD/SUD to demonstrate the physical toll these conditions take; and an increase 
attention/practice in motivational enhancement techniques. Two comments confirmed the 
usefulness and satisfaction with the session with comments to improvement of “None”, and “Do 
it for all nursing students”. 
Discussion 
 This project demonstrated that a mixed-methods contact-didactic education intervention 
yielded a reduction in stigma and an increase in nurse practitioner student confidence in 
providing care for patients with co-occurring OUD. The decrease in stigma was demonstrated in 
the statistically significant reduction in mean DDPPQ scores post intervention. Further, there was 
also a statistically significant negative correlation noted between nurse practitioner confidence 
levels as measured by the NPCS, and stigma as measured by the DDPPQ.  Suggesting that as the 
confidence level in the practitioner rose, stigma associated with drug addiction decreased. These 
findings support the literature in which Griffiths et al. (2014) described a statistically significant 
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reduction in stigma regarding mental illnesses even after a single educational intervention. 
Conversely, the mean scores on the NPCS (confidence measure) had a statistically significant 
increase after the intervention. The participants identified as most helpful the contact-based 
component, the case studies, and the resources provided.  
This project did not find a significant difference in pre or post intervention levels of 
stigma being associated with increased contact with OUD patients as determined by having 
responded affirmatively to prior MH/SUD experience. This contradicts the findings from van 
Boeckel et al., (2013) who found a relationship between those working in psychiatry and 
addiction specialists and having higher regard for patients with SUDs. This could be the result of 
these participants having been in graduate school working towards advanced practice nursing 
degrees whereas the aforementioned study focused on providers. It should also be noted that no 
respondent was a practitioner at the time of the intervention whereas the population in the van 
Boeckel study consisted of providers and did not take place in academia. The intervention in this 
project framed OUD as a medical condition similar to other diseases subject to exacerbation and 
remission. The reduction in stigma that resulted from this intervention is consistent with the 
work of Capurso and Shorter, (2017) who found that moralistic as opposed to medical views of 
addictive disorders contributed to stigma.  
Limitations 
 There were several limitations to this quality improvement project. The sample size was 
small and consisted only of educated participants in an academic setting, which could reduce 
initial rates of stigma. The sample was also relatively homogenous in terms of racial/ethnic 
background and gender. The results were not generalizable to other settings as the sample was 
not representative of the population at large. The measure to assess nurse practitioner’s 
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confidence was developed for this project, so the psychometric properties of this scale have not 
been examined.  The intervention itself was also comparatively brief and there were no 
mechanisms in place to assess or monitor the impact of the educational intervention over the 
long term. The NPCS was designed by the author for this specific intervention and not a 
validated instrument. 
Conclusion 
 This project demonstrated the efficacy of utilizing a mixed-methods contact-didactic 
education module to both increase primary care nurse practitioner confidence and reduce stigma 
towards primary care patients with co-occurring OUD. The intervention was carried out in 100 
minutes and all participants agreed that the three objectives were met. Understanding the 
importance of stigma reduction in providing care to primary care patients with co-occurring 
OUD, and more broadly, in combating the opioid epidemic, the utility of this intervention in 
taking meaningful steps to accomplish these aims is clear. 
 The intervention utilized in this project could be readily implemented into the regular 
curriculum for AGPC/FNP students. There was no cost associated with the intervention itself, 
and the material is relevant to a broader understanding of addictive disorders. Moving forward, 
the population could be broadened to include undergraduate nursing students in an academic 
setting, or floor nursing staff in a clinical setting. It is also worth noting that the NPCS could be 
validated as an instrument to measure confidence in primary care nurse practitioners or other 
primary healthcare workers.  
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Appendix A: DDPPQ 
Drug and Drug Problems Perception Questionnaire (DDPPQ) 
 
 
Please circle one number for each question. Strongly                                            Strongly 
Agree                                                 Disagree 
1. I feel I have a working knowledge of 
drugs and drug related problems. 
1          2          3          4          5          6          7 
2. I feel I know enough about the causes 
of drug problems  
1          2          3          4          5          6          7 
3. I feel I know enough about the 
physical effects of drug use to carry 
out my role when working with drug 
users. 
1          2          3          4          5          6          7 
4. I feel I know enough about the 
psychological effects of drug use to 
carry out my role when working with 
drug users. 
1          2          3          4          5          6          7 
5. I feel I know enough about the factors 
which put people at risk of developing 
drug problems to carry out my role 
when working with drug users.  
1          2          3          4          5          6          7 
6. I feel I know how to counsel drug 
users over the long term. 
1          2          3          4          5          6          7 
7. I feel I can appropriately advise my 
patients about drugs and their effects. 
1          2          3          4          5          6          7 
8. I feel I have the right to ask patients 
questions about their drug use when 
necessary. 
1          2          3          4          5          6          7 
9. I feel that my patients believe I have 
the right to ask them questions about 
their drug use when necessary. 
1          2          3          4          5          6          7 
10. I feel I have the right to ask a patient 
for any information that is relevant to 
their drug problems. 
1          2          3          4          5          6          7 
11. If I felt the need when working with 
drug users I could easily find someone 
with whom I could discuss any 
personal difficulties I might encounter. 
1          2          3          4          5          6          7 
12. If I felt the need when working with 
drug users I could easily find someone 
who would help me clarify my 
professional responsibilities.  
1          2          3          4          5          6          7 
13. If I felt the need I could easily find 
someone who would be able to help 
1          2          3          4          5          6          7 
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me formulate the best approach to a 
drug user 
14. I want to work with drug users 1          2          3          4          5          6          7 
15. I feel that there is little I can do to help 
drug users. 
1          2          3          4          5          6          7 
16. In general, I have less respect for drug 
users than for most other patients I 
work with.  
1          2          3          4          5          6          7 
17. I feel I do not have much to be proud 
of when working with drug users. 
1          2          3          4          5          6          7 
18. At times I feel I am no good at all with 
drug users. 
1          2          3          4          5          6          7 
19. On the whole, I am satisfied with the 
way I work with drug users. 
1          2          3          4          5          6          7 
20. In general, one can get satisfaction 
from working with drug users.  
1          2          3          4          5          6          7 
21. In general, it is rewarding to work 
with drug users. 
1          2          3          4          5          6          7 
22. In general, I feel I can understand drug 
users.  
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Appendix B: Adult Gerontology Primary Care and Family Nurse Practitioner Confidence 
in Caring for Persons Experiencing OUD Scale 
Adult Gerontology Primary Care and Family Nurse Practitioner Confidence in Caring for 
Persons Experiencing OUD Scale 
 
(For the following situations, please circle one answer choice only on a scale of 1-5 where 1 
means “not at all confident”, and 5 means “totally confident”) 
 
1. Approaching patients with opioid use disorders about their condition(s). 
 
1  2  3  4  5 
 
Not at all confident      Totally confident 
 
2. Engaging in motivational enhancement techniques with patients with opioid use disorders 
 
1  2  3  4  5 
  
Not at all confident      Totally confident 
 
3. Instilling hope in patients with opioid use disorders. 
 
1  2  3  4  5 
Not at all confident      Totally confident 
 
4. Providing resources or referring patients with opioid use disorders. 
 
1  2  3  4  5 
 
 Not at all confident      Totally confident 
 
 
5. Maintaining a therapeutic mindset when providing care for patients with opioid use 
disorders. 
 
1  2  3  4  5 
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Appendix C: Process Evaluation 
 
UNIVERSITY OF LOUISVILLE 
SCHOOL OF NURSING 
 
Increasing the Confidence of Adult Gerontology Primary Care and Family Nurse 
Practitioner Students in Caring for Patients with Preexisting Opioid Use Disorder  
 
Please provide feedback regarding this educational presentation. Please indicate the level of 
agreement with the following statements regarding this presentation. 
 
Objectives:  STRONGLY 
AGREE 
AGREE DISAGREE STORNGLY 
DISAGREE 
Met objective: Examine the 
importance of reducing stigma in 
caring for clients with SUD/OUD by 
AGPCNP/FNP students.   
4 3 2 1 
 Met objective: Demonstrate 
motivational enhancement 
communication techniques for use 
with clients with SUD/OUD 
4 3 2 1 
Met objective: Discuss practices and 
resources to increase confidence in 
caring for clients with SUD/OUD by 
AGPCNP/FNP students. 
4 3 2 1 
     
Amy Spain-Duncan 
Addressed the objectives 4 3 2 1 
Was clear in presentation 4 3 2 1 
Chris Hannon 
Addressed the objectives 4 3 2 1 
Was clear in presentation 4 3 2 1 
 
Please provide comments regarding this presentation: 
 





Recommendations for improvement of this presentation: 
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Appendix D: Demographic Information Sheet 
 
UNIVERSITY OF LOUISVILLE 
SCHOOL OF NURSING 
 
Please circle the appropriate response: 
 
1. Age: 20-24     25-30     31-35     36-40     40-45     45-50     50+ 
 
2. Race/ethnicity: Caucasian     Hispanic/Latino     Black/African-American      
 
Native American     Asian/Pacific Islander     Other     Prefer not to answer 
 
3. Gender: Male     Female     Other     Prefer not to answer 
 
4. Current Position: RN     FNP     AGPCNP     Other 
 
5. Years in current position: <1-2     3-6     7-10     10 or more 
 
6. Years in nursing related field: <1-2     3-6     7-10     11-15     16 or more 
 
7. Prior professional experience with mental health or substance use disorders: 
 
Yes     No 
 
a. If yes how many years: <1-5     6-10     10+    Not applicable 
 




STIGMA, OPIOID USE DISORDERS, AND PRIMARY CARE NP STUDENTS 
   
38 
Appendix E: Motivational Enhancement Resource Sheet 
Eliciting Self- Motivating Statements: 
 
Try to move the patient toward 
 
 Being open to suggestions or discussion about opioid use 
 
 Discussing problems related to opioid use (present or potential) 
 
 Expression of a desire to change his/her behavior 
 
Example: Tell me what you’ve noticed about your opioid use; has it changed over time? 
 
Affirming the Patient: 
 
     Be supportive and encouraging 
 
     Example: “I think it shows a lot of insight for you to recognize the risk to your health that  
 
your opioid use poses.” 
 
Responding to Resistance: 
 
 Examples of patient resistance 
  
 Defensiveness, denial, arguing 
 
 Interrupting, minimizing, changing the subject 
 
What to do 
 
 Reflect what the patient is saying 
 
o May prompt the opposite (desired) response 
 
 Shifting focus 
 
o If a patient says, “I can’t quit”, then say “We are just talking, maybe 
you’re not ready to quit but we can talk about ways to mitigate some of 
the risk/damage” 
 
 Rolling with resistance 
o Going with where the patient is- i.e. “Maybe you’ll decide you’re not 
ready, but here is some information for you to look over.” 
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Table 1 

















11.45-32.55 4.45 <.001 
Role Adequacy** 29.24  
(6.25) 
20.65 (6.61) 4.81-12.37 4.82 <.001 
Role Legitamcy* 8.06 (3.34) 5.94 (2.84 .86-3.38 3.57 .003 
Role Support 14.47 
(15.44) 
7.06 (3.70) -.20-15.02 2.06 .056 
Motivation* 3.29 (1.49) 2.65 (1.41) .20-1.09 3.10 .007 
Role-related Self-
esteem 
8.88 (3.35) 7.65 (3.41) -.19-2.66 1.83 .085 
Role Support 14.19 (5.04) 11.88 (5.06) -.32-4.94 1.87 .081 
NPCS** 15.06 20.88 -7.25 - -4.38 -8.65 <.001 
* Correlation is significant at the 0.05 level (two-tailed) 
** Correlation is significant at the 0.01 level (two-tailed) 
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Table 2 
Correlation Among Pre and Post DDPPQ and NPCS and Prior MH/SUD Experience 
 1 2 3 4 5 
1. DDPPQ Pretest --     
2. DDPPQ Posttest .549* --    
3. NPCS Pretest -.293 -.136 --   
4. NPCS Posttest -.354 -.483* .679** --  
5. Prior MH/SUD 
Experience 
.009 -.150 .497* .334 -- 
* Correlation is significant at the 0.05 level (two-tailed) 
** Correlation is significant at the 0.01 level (two-tailed) 
 
